14th Annual Linda Morgante MS Nurse Leadership Program
• Apply evidence-based diagnostic and assessment approaches for evaluating disease activity in the brain and spinal cord to develop individualized treatment plans in patients with MS
Nurse Practitioner Manager
University of Calgary MS Clinic
Calgary, Alberta, Canada
Amy Perrin Ross, MSN, APN
Neuroscience Program Coordinator
Loyola University Chicago Medical Center
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
Hunter College NY and Mount Sinai School of Nursing
NP Adult Health Practice PC
New York, New York
In support of improving patient care, this activity has been planned and implemented by the Annenberg Center for Health Sciences at Eisenhower and the Academy for Continued Healthcare Learning. The Annenberg Center for Health Sciences at Eisenhower is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Clinicians should consult the current manufacturers’ prescribing information for these products. ACHL and The Annenberg Center for Health Sciences at Eisenhower requires the speaker to disclose that a product is not labeled for the use under discussion.